Latest filing published 28 Apr 2011 for Brainstorm Cell Therapeutics INC., €530k.
Insider track record
No signal scores available.
Closed purchases
Based on 9 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -73.5%Entry US$220.50 · Close at T+365 US$58.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
ACCBT Corp.: trading record in brief
ACCBT Corp. is a declared insider of Brainstorm Cell Therapeutics Inc., with filings sourced from SEC (Form 4). The record holds 15 filings, for trades running from 9 August 2007 to 23 January 2011.
Every open-market trade on record is a purchase: 9 purchases worth €151k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 6 option exercises.
In size, the median ticket on the buying side is €14k. Ninety days after publication, 9 purchases show a median change of -36.7%, with the price up in 0% of them. Past outcomes like these are no guarantee of what comes next.
On 28 April 2011 came the latest disclosure, an option exercise for €530k in Brainstorm Cell Therapeutics Inc. The most recent open-market purchase was published on 17 August 2007, 7,024 days ago. The median gap between a trade and its publication by SEC (Form 4) is 7 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to ACCBT Corp.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 4,125,000 shares@ US$0.1818Common StockSEC:0001144204-11-024696:0
- 10,499,999 shares@ US$0.12Common StockSEC:0001144204-11-024696:1
- 2,000,000 shares@ US$0.1818Common StockSEC:0001181431-08-026844:0
- 4,125,000 shares@ US$0.1818Common StockSEC:0001181431-07-069850:0
- 1,181,925 sharesCommon StockSEC:0001181431-07-056698:0
- 8,500 shares@ US$1.0247Common StockSEC:0000898430-07-003185:0Canonical exit: 7 Nov 2007 (T+90)
- 66,500 shares@ US$1.01Common StockSEC:0000898430-07-003185:1Canonical exit: 7 Nov 2007 (T+90)
- 13,500 shares@ US$1.00Common StockSEC:0000898430-07-003185:2Canonical exit: 8 Nov 2007 (T+90)
- 20,500 shares@ US$0.9663Common StockSEC:0000898430-07-003185:3Canonical exit: 8 Nov 2007 (T+90)
- 16,000 shares@ US$1.05Common StockSEC:0000898430-07-003185:4Canonical exit: 11 Nov 2007 (T+90)
- 29,500 shares@ US$1.0491Common StockSEC:0000898430-07-003185:5Canonical exit: 11 Nov 2007 (T+90)
- 20,500 shares@ US$1.0797Common StockSEC:0000898430-07-003185:6Canonical exit: 12 Nov 2007 (T+90)
- 20,500 shares@ US$1.0597Common StockSEC:0000898430-07-003185:7Canonical exit: 13 Nov 2007 (T+90)
- 4,500 shares@ US$1.07Common StockSEC:0000898430-07-003185:8Canonical exit: 13 Nov 2007 (T+90)
- 6,875,000 shares@ US$0.1818Common StockSEC:0000898430-07-003185:9
15 of 15 declarations